The ability of tumor volume to predict local control in surgically treated squamous cell carcinoma of the supraglottic larynx

Head and Neck

Volumn 22, Issue 3, 2000, Pages 282-287

  Mukherji, Suresh K ^a   O'Brien, Sean M ^a   Gerstle, Ronald J ^a   Weissler, Mark ^a   Shockley, William ^a   Stone, Jeffrey A ^a   Castillo, Mauricio ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

CT tumor volume; Head and neck cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LARYNX CARCINOMA; MALE; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; EPIGLOTTIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0034003894     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(200005)22:3<282::AID-HED11>3.0.CO;2-K     Document Type: Article

References (32)

1. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the supraglottic larynx treated with radical irradiation: analysis of treatment parameters and results. Int J Radiat Oncol Biol Phys 1984;10:2223-2230.
2. Weems DH, Mendenhall WM, Parsons JT, et al. Squamous cell carcinoma of the supraglottic larynx treated with surgery and/or radiation therapy. Int J Radiat Oncol Biol Phys 1987;13:1483-1487.
3. Goepfert H, Jesse RH, Pletcher GH, et al. Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx. Laryngoscope 1975;85: 14-32.
4. Isaacs JH, Manucso AA, Mendenhall WM. CT scanning as an aid to selection of therapy in T2-T4 laryngeal cancer. Head Neck Surg 1988;99:455-464.
5. Lee NK, Goepfert H, Wendt CD. Supraglottic laryngectomy for intermediate-stage cancer: UTMD Anderson Cancer Center experience with combined therapy. Laryngoscope 1990;100:831-836.
6. Robbins KT, Davidson W, Peters LJ, et al. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx. Arch Otolaryngol Head Neck Surg 1998;114:421-426.
7. Fletcher GH, Jesse RH, Lindberg RD, et al. The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx. Am J Roentgenol 1970;108:19-26.
8. Fletcher GH, Hamberger AD. Causes of failure in irradiation of squamous-cell carcinoma of the supraglottic larynx. Radiology 1974;111:697-700.
9. Harwood AR, Beale FA, Cummings BJ, et al. Management of early supraglottic laryngeal carcinoma by irradiation with surgery in reserve. Arch Otolaryngol 1983;109: 583-585.
10. Million RR, Cassisi NJ, Mancuso AA. Larynx. In: Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach, ed 2. Philadelphia: Lippincott; 1994. p 431-503.
11. Mancuso AA, Hanafee WN. Larynx and hypopharynx. In: Computed tomography and magnetic resonance imaging of the head and neck. 2nd ed. Baltimore: Williams & Wilkins; 1985. p 241-357.
12. American Joint Committee on Cancer, Beahrs OH, et al, editors. Manual for staging of cancer, ed. 3: Pharynx (including base of tongue, soft palate, and uvula). Philadelphia: J B Lippincott; 1988. p 30-38.
13. Desanto, LW. Supraglottic laryngectomy. In: Bailey B, editor. Head and neck surgery otolaryngology. Philadelphia: J B Lippincott; 1993. p 1334-1346.
14. Curtin HD. Larynx. In: Som PM, Curtin HD, editors. Head and neck imaging. 3rd ed. St Louis: Mosby-Year Book; 1995. p 612-707.
15. Mukherji SK, Pillsbury H, Castillo M. Imaging squamous cell carcinomas of the upper aerodigestive tract: what the clinicians need to know. Radiology 1997;205:629-646.
16. Chua DTT, Sham JST, Kwong DLW, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997;39:711-719.
17. Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor estimates derived from computed tomography. Int J Radiat Oncol Biol Phys 1995;33:281-287.
18. Mancuso AA, Mukherji SK, Kotzur, et al. Preradiotherapy-computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999; 17: 631-63.
19. Freeman DE, Mancuso AA, Parsons JT, et al. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int J Radiat Oncol Biol Phys 1990;19:485-490.
20. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Mukherji SK, Kubilis PS. Can pretreatment computed tomography predict local control in pyriform sinus carcinoma treated with definitive radiotherapy? Head Neck 1998;20:159-168.
21. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Kubilis PS. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncology Biol Phys 1997;37:1011-1021.
22. Lee WR, Mancuso AA, Saleh EM, et al. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinomas of the glottic larynx treated with radiotherapy alone? Int J Radiat Oncol Biol Phys 1993;25:683-687.
23. Gilbert RW, Birt D, Shulman H, et al. Correlation of tumor volume with local control in laryngeal carcinoma treated by radiotherapy. Ann Otol Rhinol Laryngol 1987; 96:514-518.
24. Hermans R, Feron M, Bellon E, Dupont P, Van den Bogaert W, Baert AL. Variability of laryngeal tumor volume measurements determined with CT. Int J Radiat Oncol Biol Phys 1998;40:553-557.
25. Koziol JA. On maximally selected chi-square statistics. Biometrics 1991;47:1557-1561.
26. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-835.
27. Castelijns JA, Van Den Brekel MWM, Smit EMT, et al. Predictive value of MR imaging-dependent and non-MR imaging-dependent parameters for recurrent laryngeal cancer after radiation therapy. Radiology 1995;196: 735-739.
28. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: Preliminary results of a European organization for research and treatment of cancer Phase III trial. J Natl Cancer Inst 1996;88:890-898.
29. Koch WM, Brennan JA, Zahurak M, et al. p53 Mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88: 1580-1586.
30. Liggett WH Jr, Sewell DA, Rocco J, et al. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 1996;56: 4119-4123.
31. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56: 3630-3633.
32. Yao SL, Akhtar AJ, McKenna KA, et al. Selective radio-sensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nature Med 1996;2: 1140-1143.